Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.3%

2 terminated/withdrawn out of 24 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

21%

5 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
11(68.8%)
Phase 4
4(25.0%)
Phase 3
1(6.3%)
16Total
N/A(11)
Phase 4(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07233837Not ApplicableRecruiting

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Role: collaborator

NCT07424859Not ApplicableCompleted

Evaluation of Yoga and Conventional Physical Exercise for Pain and Quality of Life in Women With Endometriosis: A Randomized Clinical Trial

Role: lead

NCT07293533Enrolling By Invitation

Brazilian System for Cardiac Operative Risk Evaluation CABG

Role: collaborator

NCT07093450Not ApplicableRecruiting

Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients

Role: collaborator

NCT05673226Not ApplicableCompleted

Organosilane for Surface Cleaning in Intensive Care Units

Role: collaborator

NCT05617638Not ApplicableSuspended

Impact of Virtual Reality (e-Nature VR) During Hospitalization in Adult Intensive Care Unit

Role: collaborator

NCT06342115Phase 4Recruiting

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Role: lead

NCT02338947Not ApplicableActive Not Recruiting

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

Role: collaborator

NCT06426277Not ApplicableRecruiting

Effectiveness of the Brazilian Diabetes Prevention Program

Role: lead

NCT06721442Phase 4Completed

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Role: lead

NCT05277935Not ApplicableRecruiting

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

Role: lead

NCT06412549Not ApplicableNot Yet Recruiting

Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices (ICP Monitor e EVD)

Role: lead

NCT06412523Active Not Recruiting

Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil

Role: lead

NCT05689658Not ApplicableCompleted

Brazilian Diabetes Prevention Program: Pilot Study

Role: lead

NCT04746339Phase 4Terminated

Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19

Role: collaborator

NCT04376658Completed

Quality of Life and Long-term Outcomes After Hospitalization for COVID-19

Role: collaborator

NCT05363696Completed

The REPLICCAR Registry and The Statewide Quality Improvement Initiative

Role: collaborator

NCT05287139Unknown

QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.

Role: lead

NCT04983433Unknown

Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology

Role: lead

NCT04394377Phase 4Completed

Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial

Role: collaborator